Kenya

Last Updated 5 March 2021.

1 Vaccine Approved for Use in Kenya

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 countries

  22 trials in 13 countries

  Non Replicating Viral Vector

1 Vaccine in Clinical Trials in Kenya

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 countries

  22 trials in 13 countries

  Non Replicating Viral Vector